Drugs / Erythropoietin-α
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04040023 | Sep 2019 → Jul 2021 | — | Clinique Pasteur | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Erythropoietin-α | “using intravenous iron (1000 mg ferric carboxymaltose) and erythropoietin-α (600 IU/kg weekly, 1-3 doses).” PMID 41483954 ↗ Nov 2025 |